Skip to main content
. 2017 Mar 14;10:1585–1601. doi: 10.2147/OTT.S100513

Figure 1.

Figure 1

Comparison of OS in the ALLG APML4 and ALLG APML3 trials.

Note: Figure was provided courtesy of H Iland (APML4 principal investigator) from the Australasian Leukaemia and Lymphoma Group APML4 Statistical Report (June 2013) by Collins M, Di Iulio J, and Beresford J (unpublished).

Abbreviations: OS, overall survival; ALLG, Australasian Leukaemia and Lymphoma Group; HR, hazard ratio; CI, confidence interval; ATRA, all trans-retinoic acid.